Where They’re Going: David Nesterov-Rappoport C’22

“Drew provided me with a foundation on which to build my software engineering expertise.”

May 2022 – We’re taking a look at where some of the Drew University College of Liberal Arts Class of 2022 is heading.

David Nesterov-Rappoport C’22

Computer science and philosophy double major, data science minor

Baldwin Honors scholar, chief editor of The Drew Review, creative lead at TEDxDrewU, president of Drew University Philosophical Society, programming fellow and tutor at the Center for Academic Excellence, Drew Summer Science Institute fellow, member of Phi Beta Kappa (liberal arts and sciences) and Phi Sigma Tau (philosophy) honors societies, Jane Brown and Albert Norton Wettstein Prize winner, Award in Science for Computer Science.

Where he’s going

Nesterov-Rappoport will be a software engineer at Chainalysis, a New York City based blockchain analysis company that provides data, software, services, and research to government agencies, exchanges, financial institutions, and insurance and cybersecurity companies.

In his own words

“Drew provided me with a foundation on which to build my software engineering expertise. The school provided numerous opportunities to build websites for real clients both in and outside of class, helped me secure a valuable internship with AFreeBird, and allowed me to do research during the summers through Drew Summer Science Institute (DSSI) and Digital Humanities Summer Institute (DHSI). These experiences contributed to a steady evolution of my skills and portfolio, which eventually helped me land the job with Chainalysis.”

more on the class of 2022

Related Posts

Drew University Professor Publishes Book on Literature and Film in India

Shakti Jaising's book bridges gaps through cross-national analysis


Drew University Professor To Appear in Jeopardy! Tournament of Champions

Brianne Barker returns after 2022 victory


Discoverers of Groundbreaking New Lung Cancer Treatment Honored as Heroes in Drug Discovery

Students learn about drug discovery process from industry experts